Published in TB and Outbreaks Week, January 7th, 2003
Aventis Pasteur's Swiftwater, Pennsylvania, facility currently produces about half the influenza vaccine used in the U.S. Aventis Pasteur globally produces more than half the influenza vaccine used in the world.
Aventis Pasteur recently announced an $80 million investment to increase filling and formulation capacity at its Swiftwater facility. The company is in the process of evaluating a still greater expansion within the next several years to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week